AstraZeneca To Take 44% Stake In French Firm For $245M
AstraZeneca PLC will take a 44% stake in French biopharmaceutical company Cellectis via a $245 million cash investment, the companies said on Wednesday, in a move to help speed up the...To view the full article, register now.
Already a subscriber? Click here to view full article